Editorial: Escalation to weekly dosing in adalimumab-treated patients with active ulcerative colitis

Aliment Pharmacol Ther. 2014 Sep;40(6):730-1. doi: 10.1111/apt.12896.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Anti-Inflammatory Agents / administration & dosage*
  • Antibodies, Monoclonal, Humanized / administration & dosage*
  • Colitis, Ulcerative / drug therapy*
  • Female
  • Humans
  • Male
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal, Humanized
  • Tumor Necrosis Factor-alpha